Back to News
Market Impact: 0.3
Evolus, Inc. Reports Third Quarter 2026 Global Net Revenue of $78.0 Million and Reaffirms Full-Year Revenue Guidance
Source: Nasdaq
Corporate EarningsCompany FundamentalsHealthcare & Biotech
Evolus reported third-quarter 2026 global net revenue of $78.0 million, up 13% year over year. Revenue included $70.1 million from global toxin sales and $7.9 million from other sources; the supplied article text ends before further results are provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
EOLS0.55
More News
- Tech stocks are suffering their biggest selloff since Covid, as investors see premature end to AI datacenter boom
- Elon Musk's Tesla and SpaceX lose over $420 billion in combined market cap after midterms
- Qualcomm slides 9% after earnings, leading post-election chip stock sell-off
- Costco is taking aim at its May record high — how it got here and where's it going
- Neocloud IREN says $4 billion in annualized revenue being delayed due to customer request
- Tapestry CEO on Earnings Beat, Consumer Outlook